

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-amino acid import (GO:0043092) | 9.51451944 |
| 2 | embryonic body morphogenesis (GO:0010172) | 8.55789159 |
| 3 | gamma-aminobutyric acid transport (GO:0015812) | 7.64230083 |
| 4 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 7.51129376 |
| 5 | poly(A)+ mRNA export from nucleus (GO:0016973) | 7.26120168 |
| 6 | modulation by virus of host process (GO:0019054) | 7.20910286 |
| 7 | body morphogenesis (GO:0010171) | 7.18520818 |
| 8 | leukocyte aggregation (GO:0070486) | 6.96370236 |
| 9 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 6.76661865 |
| 10 | neurofilament cytoskeleton organization (GO:0060052) | 6.74707700 |
| 11 | activation of MAPKKK activity (GO:0000185) | 6.49863210 |
| 12 | amino acid import (GO:0043090) | 6.27754240 |
| 13 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 5.83277355 |
| 14 | modulation by symbiont of host cellular process (GO:0044068) | 5.62521039 |
| 15 | regulation of translational fidelity (GO:0006450) | 5.54554340 |
| 16 | neuron fate determination (GO:0048664) | 5.53459104 |
| 17 | translational termination (GO:0006415) | 4.89121661 |
| 18 | viral transcription (GO:0019083) | 4.85239577 |
| 19 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.83122305 |
| 20 | amyloid precursor protein catabolic process (GO:0042987) | 4.77462772 |
| 21 | negative regulation of viral entry into host cell (GO:0046597) | 4.74593168 |
| 22 | adaptation of signaling pathway (GO:0023058) | 4.73399343 |
| 23 | ribosomal small subunit assembly (GO:0000028) | 4.53853170 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 4.46168093 |
| 25 | negative regulation of viral release from host cell (GO:1902187) | 4.44085423 |
| 26 | neutral amino acid transport (GO:0015804) | 4.44066671 |
| 27 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 4.43395124 |
| 28 | skin morphogenesis (GO:0043589) | 4.42840634 |
| 29 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.32846126 |
| 30 | hematopoietic stem cell differentiation (GO:0060218) | 4.25455991 |
| 31 | N-glycan processing (GO:0006491) | 4.25153559 |
| 32 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.14748345 |
| 33 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 4.09298878 |
| 34 | piRNA metabolic process (GO:0034587) | 4.03375684 |
| 35 | viral life cycle (GO:0019058) | 4.02551224 |
| 36 | intermediate filament organization (GO:0045109) | 3.91079356 |
| 37 | glycoprotein catabolic process (GO:0006516) | 3.86489449 |
| 38 | cellular protein complex disassembly (GO:0043624) | 3.82503052 |
| 39 | ribosomal small subunit biogenesis (GO:0042274) | 3.80378018 |
| 40 | translational elongation (GO:0006414) | 3.71825676 |
| 41 | rRNA transcription (GO:0009303) | 3.71056614 |
| 42 | phosphatidylserine metabolic process (GO:0006658) | 3.69626240 |
| 43 | heart valve formation (GO:0003188) | 3.63353222 |
| 44 | positive regulation of gastrulation (GO:2000543) | 3.60415977 |
| 45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.57574545 |
| 46 | regulation of transmission of nerve impulse (GO:0051969) | 3.55928406 |
| 47 | L-amino acid transport (GO:0015807) | 3.53476893 |
| 48 | cotranslational protein targeting to membrane (GO:0006613) | 3.52003893 |
| 49 | protein targeting to ER (GO:0045047) | 3.51985736 |
| 50 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 3.49093737 |
| 51 | response to pheromone (GO:0019236) | 3.45536604 |
| 52 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.42090186 |
| 53 | UV protection (GO:0009650) | 3.38228403 |
| 54 | induction of positive chemotaxis (GO:0050930) | 3.36978109 |
| 55 | iron-sulfur cluster assembly (GO:0016226) | 3.35930591 |
| 56 | metallo-sulfur cluster assembly (GO:0031163) | 3.35930591 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 3.34578409 |
| 58 | beta-amyloid metabolic process (GO:0050435) | 3.33344497 |
| 59 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.31115462 |
| 60 | protein localization to endoplasmic reticulum (GO:0070972) | 3.30157645 |
| 61 | regulation of viral entry into host cell (GO:0046596) | 3.28391145 |
| 62 | protein polyglutamylation (GO:0018095) | 3.20528081 |
| 63 | protein complex disassembly (GO:0043241) | 3.05426411 |
| 64 | neuronal action potential propagation (GO:0019227) | 3.04334768 |
| 65 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.03353437 |
| 66 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.00531378 |
| 67 | positive regulation of mesonephros development (GO:0061213) | 2.99478693 |
| 68 | DNA methylation involved in gamete generation (GO:0043046) | 2.99044357 |
| 69 | regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516) | 2.98421990 |
| 70 | spinal cord development (GO:0021510) | 2.93629823 |
| 71 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.92337870 |
| 72 | regulation of translational elongation (GO:0006448) | 2.89608809 |
| 73 | negative regulation of receptor activity (GO:2000272) | 2.89590764 |
| 74 | regulation of viral release from host cell (GO:1902186) | 2.87884596 |
| 75 | ATP synthesis coupled proton transport (GO:0015986) | 2.87423044 |
| 76 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.87423044 |
| 77 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85179627 |
| 78 | cellular response to pH (GO:0071467) | 2.83863583 |
| 79 | positive regulation of defense response to virus by host (GO:0002230) | 2.81487990 |
| 80 | macromolecular complex disassembly (GO:0032984) | 2.80595835 |
| 81 | alditol phosphate metabolic process (GO:0052646) | 2.80398028 |
| 82 | negative regulation of potassium ion transport (GO:0043267) | 2.80240161 |
| 83 | modulation by virus of host morphology or physiology (GO:0019048) | 2.79719404 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72468079 |
| 85 | translational initiation (GO:0006413) | 2.67902631 |
| 86 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 2.67332023 |
| 87 | male meiosis I (GO:0007141) | 2.63541861 |
| 88 | positive regulation of prostaglandin secretion (GO:0032308) | 2.61285997 |
| 89 | neurotransmitter secretion (GO:0007269) | 2.60622997 |
| 90 | positive regulation of protein kinase C signaling (GO:0090037) | 2.59744650 |
| 91 | rRNA catabolic process (GO:0016075) | 2.58094010 |
| 92 | dorsal/ventral neural tube patterning (GO:0021904) | 2.57586451 |
| 93 | regulation of mesonephros development (GO:0061217) | 2.57471938 |
| 94 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.53866375 |
| 95 | amyloid precursor protein metabolic process (GO:0042982) | 2.53728917 |
| 96 | pattern specification involved in kidney development (GO:0061004) | 2.53514854 |
| 97 | regulation of respiratory burst (GO:0060263) | 2.50907735 |
| 98 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 2.49000516 |
| 99 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.47915947 |
| 100 | glycine transport (GO:0015816) | 16.6011393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.78531056 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.16313954 |
| 3 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 3.05466714 |
| 4 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.79459056 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.76015700 |
| 6 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.75795701 |
| 7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74519865 |
| 8 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.67787263 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.60378950 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.51228505 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42201849 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.38089057 |
| 13 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.37225335 |
| 14 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35391175 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29658539 |
| 16 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.26933339 |
| 17 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.21553010 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16390294 |
| 19 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.13324158 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02336596 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02336596 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95997801 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.94824744 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.93816340 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.91147781 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90527472 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.88862726 |
| 28 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.86989016 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.86391758 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.85633237 |
| 31 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85338280 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80567415 |
| 33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.72950617 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71111894 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64973057 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61120663 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55962106 |
| 38 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.48362386 |
| 39 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.44729249 |
| 40 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44293232 |
| 41 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.44132606 |
| 42 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.41825603 |
| 43 | KDM2B_26808549_Chip-Seq_REH_Human | 1.40131999 |
| 44 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.36604442 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35943754 |
| 46 | ERA_21632823_ChIP-Seq_H3396_Human | 1.34421814 |
| 47 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30120106 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28326925 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26245579 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21494435 |
| 51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20563410 |
| 52 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.19916079 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18825575 |
| 54 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.18347789 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17209968 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16073479 |
| 57 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.14393578 |
| 58 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.13198223 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12841307 |
| 60 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.12699180 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11928443 |
| 62 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.11496086 |
| 63 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10456914 |
| 64 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.09589783 |
| 65 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.09202430 |
| 66 | AR_20517297_ChIP-Seq_VCAP_Human | 1.09066696 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09057207 |
| 68 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.08791858 |
| 69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02109332 |
| 70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99461902 |
| 71 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98958644 |
| 72 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97652779 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93809129 |
| 74 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92516673 |
| 75 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.91117251 |
| 76 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.90568463 |
| 77 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.90148391 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89462151 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.88929775 |
| 80 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.88554298 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87568209 |
| 82 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.86865716 |
| 83 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.86656764 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86235177 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85787591 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85787591 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85041475 |
| 88 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.84559363 |
| 89 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.83896205 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82302939 |
| 91 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.81635846 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81604169 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81403919 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81231890 |
| 95 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.80891514 |
| 96 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.80891514 |
| 97 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.80825899 |
| 98 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80578802 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80502129 |
| 100 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.80464577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000013_abnormal_adipose_tissue | 6.51835577 |
| 2 | MP0006054_spinal_hemorrhage | 5.22924794 |
| 3 | MP0005623_abnormal_meninges_morphology | 5.07360875 |
| 4 | MP0003136_yellow_coat_color | 5.02717142 |
| 5 | MP0004142_abnormal_muscle_tone | 4.90129356 |
| 6 | MP0003385_abnormal_body_wall | 4.51179709 |
| 7 | MP0000750_abnormal_muscle_regeneration | 3.56246005 |
| 8 | MP0003646_muscle_fatigue | 3.12749294 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.70299748 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.55500743 |
| 11 | MP0001486_abnormal_startle_reflex | 2.34390840 |
| 12 | MP0002938_white_spotting | 2.31281948 |
| 13 | MP0003329_amyloid_beta_deposits | 2.07388174 |
| 14 | MP0000003_abnormal_adipose_tissue | 2.04854729 |
| 15 | MP0001188_hyperpigmentation | 1.99638333 |
| 16 | MP0009379_abnormal_foot_pigmentation | 1.96028035 |
| 17 | MP0005503_abnormal_tendon_morphology | 1.88001227 |
| 18 | MP0003567_abnormal_fetal_cardiomyocyte | 1.83467863 |
| 19 | MP0009384_cardiac_valve_regurgitation | 1.82537433 |
| 20 | MP0005171_absent_coat_pigmentation | 1.80971687 |
| 21 | MP0001727_abnormal_embryo_implantation | 1.72493931 |
| 22 | MP0009250_abnormal_appendicular_skeleto | 1.71558315 |
| 23 | MP0003786_premature_aging | 1.56137644 |
| 24 | MP0001984_abnormal_olfaction | 1.54619838 |
| 25 | MP0004381_abnormal_hair_follicle | 1.50455897 |
| 26 | MP0003283_abnormal_digestive_organ | 1.37770534 |
| 27 | MP0001324_abnormal_eye_pigmentation | 1.37439730 |
| 28 | MP0009697_abnormal_copulation | 1.34344631 |
| 29 | MP0005369_muscle_phenotype | 1.33895501 |
| 30 | MP0000604_amyloidosis | 1.33744088 |
| 31 | MP0004134_abnormal_chest_morphology | 1.32334613 |
| 32 | MP0000762_abnormal_tongue_morphology | 1.29472247 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.28250929 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.27890373 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.26642336 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.26252905 |
| 37 | MP0005671_abnormal_response_to | 1.25420903 |
| 38 | MP0002089_abnormal_postnatal_growth/wei | 1.24903564 |
| 39 | MP0002272_abnormal_nervous_system | 1.23421969 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.23362730 |
| 41 | MP0002177_abnormal_outer_ear | 1.19766189 |
| 42 | MP0004147_increased_porphyrin_level | 1.14821910 |
| 43 | MP0004858_abnormal_nervous_system | 1.11882190 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.11302330 |
| 45 | MP0000955_abnormal_spinal_cord | 1.11082368 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.10667033 |
| 47 | MP0000751_myopathy | 1.09968094 |
| 48 | MP0000749_muscle_degeneration | 1.09954058 |
| 49 | MP0004947_skin_inflammation | 1.06692436 |
| 50 | MP0000647_abnormal_sebaceous_gland | 1.05851307 |
| 51 | MP0002108_abnormal_muscle_morphology | 1.03645234 |
| 52 | MP0002269_muscular_atrophy | 1.01620133 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.01087850 |
| 54 | MP0004215_abnormal_myocardial_fiber | 0.88993044 |
| 55 | MP0004885_abnormal_endolymph | 0.88766769 |
| 56 | MP0004087_abnormal_muscle_fiber | 0.86977493 |
| 57 | MP0001986_abnormal_taste_sensitivity | 0.85488199 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 0.85397991 |
| 59 | MP0002095_abnormal_skin_pigmentation | 0.82849477 |
| 60 | MP0003635_abnormal_synaptic_transmissio | 0.82358110 |
| 61 | MP0008872_abnormal_physiological_respon | 0.82251164 |
| 62 | MP0000613_abnormal_salivary_gland | 0.80894751 |
| 63 | MP0005360_urolithiasis | 0.80470273 |
| 64 | MP0002163_abnormal_gland_morphology | 0.79276025 |
| 65 | MP0009053_abnormal_anal_canal | 0.78201279 |
| 66 | MP0001915_intracranial_hemorrhage | 0.77724633 |
| 67 | MP0008775_abnormal_heart_ventricle | 0.77076532 |
| 68 | MP0000759_abnormal_skeletal_muscle | 0.76220945 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.75763486 |
| 70 | MP0004133_heterotaxia | 0.72416722 |
| 71 | MP0005375_adipose_tissue_phenotype | 0.72381167 |
| 72 | MP0002638_abnormal_pupillary_reflex | 0.71915981 |
| 73 | MP0005423_abnormal_somatic_nervous | 0.71774154 |
| 74 | MP0009046_muscle_twitch | 0.71429231 |
| 75 | MP0003436_decreased_susceptibility_to | 0.70947380 |
| 76 | MP0001968_abnormal_touch/_nociception | 0.69543204 |
| 77 | MP0001348_abnormal_lacrimal_gland | 0.68455558 |
| 78 | MP0000467_abnormal_esophagus_morphology | 0.68276853 |
| 79 | MP0009745_abnormal_behavioral_response | 0.68143572 |
| 80 | MP0000377_abnormal_hair_follicle | 0.67587078 |
| 81 | MP0001299_abnormal_eye_distance/ | 0.66855678 |
| 82 | MP0003868_abnormal_feces_composition | 0.65934663 |
| 83 | MP0003115_abnormal_respiratory_system | 0.65858970 |
| 84 | MP0005195_abnormal_posterior_eye | 0.60585827 |
| 85 | MP0002160_abnormal_reproductive_system | 0.59385441 |
| 86 | MP0008995_early_reproductive_senescence | 0.57708897 |
| 87 | MP0001542_abnormal_bone_strength | 0.57122837 |
| 88 | MP0003011_delayed_dark_adaptation | 0.56005425 |
| 89 | MP0005193_abnormal_anterior_eye | 0.55659904 |
| 90 | MP0003755_abnormal_palate_morphology | 0.55178951 |
| 91 | MP0003633_abnormal_nervous_system | 0.53134161 |
| 92 | MP0009785_altered_susceptibility_to | 0.53059990 |
| 93 | MP0002752_abnormal_somatic_nervous | 0.53025638 |
| 94 | MP0000778_abnormal_nervous_system | 0.53017731 |
| 95 | MP0003195_calcinosis | 0.52379710 |
| 96 | MP0004130_abnormal_muscle_cell | 0.52293350 |
| 97 | MP0003936_abnormal_reproductive_system | 0.52280519 |
| 98 | MP0001879_abnormal_lymphatic_vessel | 0.49133813 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 0.48684037 |
| 100 | MP0000858_altered_metastatic_potential | 0.46290679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebellar dysplasia (HP:0007033) | 8.79886347 |
| 2 | Retinal atrophy (HP:0001105) | 8.70694274 |
| 3 | Type II lissencephaly (HP:0007260) | 8.57348659 |
| 4 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 8.50055679 |
| 5 | Agnosia (HP:0010524) | 7.82256665 |
| 6 | Retinal dysplasia (HP:0007973) | 7.41997768 |
| 7 | Muscle stiffness (HP:0003552) | 5.79129886 |
| 8 | Disinhibition (HP:0000734) | 5.29259543 |
| 9 | Hypoplasia of the pons (HP:0012110) | 5.08741147 |
| 10 | Lower limb hyperreflexia (HP:0002395) | 5.02427773 |
| 11 | Abnormality of the pons (HP:0007361) | 4.89434028 |
| 12 | Fatigue (HP:0012378) | 4.30365903 |
| 13 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.06197749 |
| 14 | Personality changes (HP:0000751) | 3.98283298 |
| 15 | Difficulty climbing stairs (HP:0003551) | 3.89988358 |
| 16 | Lissencephaly (HP:0001339) | 3.75788922 |
| 17 | Neck muscle weakness (HP:0000467) | 3.65926083 |
| 18 | Buphthalmos (HP:0000557) | 3.58454451 |
| 19 | Severe muscular hypotonia (HP:0006829) | 3.56434126 |
| 20 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.54406403 |
| 21 | Inappropriate behavior (HP:0000719) | 3.45877477 |
| 22 | Axonal loss (HP:0003447) | 3.39272160 |
| 23 | Increased IgM level (HP:0003496) | 3.36202448 |
| 24 | Upper motor neuron abnormality (HP:0002127) | 3.29907438 |
| 25 | Mask-like facies (HP:0000298) | 3.24404954 |
| 26 | Progressive external ophthalmoplegia (HP:0000590) | 3.18600920 |
| 27 | Abolished electroretinogram (ERG) (HP:0000550) | 3.13337412 |
| 28 | Abnormality of the vitreous humor (HP:0004327) | 3.01965053 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.99884335 |
| 30 | Abnormality of DNA repair (HP:0003254) | 2.98173957 |
| 31 | Poikiloderma (HP:0001029) | 2.91038412 |
| 32 | Entropion (HP:0000621) | 2.89977227 |
| 33 | Amyotrophic lateral sclerosis (HP:0007354) | 2.74319917 |
| 34 | Flat capital femoral epiphysis (HP:0003370) | 2.71359745 |
| 35 | Pachygyria (HP:0001302) | 2.55155590 |
| 36 | Concave nail (HP:0001598) | 2.55085310 |
| 37 | Muscle fiber inclusion bodies (HP:0100299) | 2.54573031 |
| 38 | Spastic tetraparesis (HP:0001285) | 2.50601682 |
| 39 | Nemaline bodies (HP:0003798) | 2.49183706 |
| 40 | IgG deficiency (HP:0004315) | 2.47790963 |
| 41 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.41824789 |
| 42 | True hermaphroditism (HP:0010459) | 2.31281816 |
| 43 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.29404102 |
| 44 | Generalized muscle weakness (HP:0003324) | 2.23721577 |
| 45 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.16685731 |
| 46 | Memory impairment (HP:0002354) | 2.14814456 |
| 47 | Polyphagia (HP:0002591) | 2.14439904 |
| 48 | Abnormality of the right ventricle (HP:0001707) | 2.13773140 |
| 49 | Non-midline cleft lip (HP:0100335) | 2.11956466 |
| 50 | Pallor (HP:0000980) | 2.09185677 |
| 51 | Calf muscle hypertrophy (HP:0008981) | 2.08662611 |
| 52 | Megalocornea (HP:0000485) | 2.08169914 |
| 53 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.07857058 |
| 54 | Meningocele (HP:0002435) | 2.03922101 |
| 55 | Pancreatic fibrosis (HP:0100732) | 2.03403041 |
| 56 | Sclerocornea (HP:0000647) | 2.02337309 |
| 57 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99871051 |
| 58 | Chronic hepatic failure (HP:0100626) | 1.99093653 |
| 59 | Hepatitis (HP:0012115) | 1.98901286 |
| 60 | Congenital, generalized hypertrichosis (HP:0004540) | 1.91491981 |
| 61 | Abnormality of midbrain morphology (HP:0002418) | 1.90390860 |
| 62 | Molar tooth sign on MRI (HP:0002419) | 1.90390860 |
| 63 | Basal ganglia calcification (HP:0002135) | 1.89441204 |
| 64 | CNS hypomyelination (HP:0003429) | 1.89204867 |
| 65 | Congenital glaucoma (HP:0001087) | 1.88327231 |
| 66 | Gowers sign (HP:0003391) | 1.85513512 |
| 67 | Patellar aplasia (HP:0006443) | 1.83087500 |
| 68 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.82419329 |
| 69 | Hypoplasia of the brainstem (HP:0002365) | 1.82419329 |
| 70 | Abnormality of the motor neurons (HP:0002450) | 1.80075646 |
| 71 | Abnormal neuron morphology (HP:0012757) | 1.80075646 |
| 72 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.80017475 |
| 73 | Decreased circulating renin level (HP:0003351) | 1.79595731 |
| 74 | Absent phalangeal crease (HP:0006109) | 1.78718323 |
| 75 | Nephropathy (HP:0000112) | 1.78026349 |
| 76 | Absent thumb (HP:0009777) | 1.74192048 |
| 77 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.72767905 |
| 78 | Polymicrogyria (HP:0002126) | 1.69431388 |
| 79 | Bone cyst (HP:0012062) | 1.68055326 |
| 80 | Subacute progressive viral hepatitis (HP:0006572) | 1.67144606 |
| 81 | Hypoplasia of the uterus (HP:0000013) | 1.64627150 |
| 82 | Type 1 muscle fiber predominance (HP:0003803) | 1.63445110 |
| 83 | Mesangial abnormality (HP:0001966) | 1.63376329 |
| 84 | Muscular dystrophy (HP:0003560) | 1.63231437 |
| 85 | Metabolic alkalosis (HP:0200114) | 1.62906942 |
| 86 | Reticulocytopenia (HP:0001896) | 1.61089416 |
| 87 | Fragile nails (HP:0001808) | 1.59435928 |
| 88 | Nephrogenic diabetes insipidus (HP:0009806) | 1.58449312 |
| 89 | Abnormal finger flexion creases (HP:0006143) | 1.58373762 |
| 90 | Cerebral inclusion bodies (HP:0100314) | 1.56991391 |
| 91 | Focal motor seizures (HP:0011153) | 1.55749997 |
| 92 | Dandy-Walker malformation (HP:0001305) | 1.54541601 |
| 93 | Sacral dimple (HP:0000960) | 1.54119724 |
| 94 | Synostosis of carpal bones (HP:0005048) | 1.53708302 |
| 95 | Recurrent bacterial skin infections (HP:0005406) | 1.49998102 |
| 96 | Encephalitis (HP:0002383) | 1.49135461 |
| 97 | Syncope (HP:0001279) | 1.48204220 |
| 98 | Hypoplasia of the radius (HP:0002984) | 1.47782424 |
| 99 | Papilledema (HP:0001085) | 1.47403644 |
| 100 | Conjugated hyperbilirubinemia (HP:0002908) | 1.45907324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK3 | 4.68588638 |
| 2 | ARAF | 4.61080128 |
| 3 | STK10 | 4.47981104 |
| 4 | BCKDK | 4.42228942 |
| 5 | MAP3K13 | 3.88260378 |
| 6 | MAP3K9 | 3.39871525 |
| 7 | TNIK | 2.48711310 |
| 8 | SCYL2 | 2.45304084 |
| 9 | OBSCN | 2.40153202 |
| 10 | EIF2AK1 | 2.17763424 |
| 11 | PTK2B | 2.12955956 |
| 12 | WNK4 | 2.12467500 |
| 13 | MOS | 2.09070382 |
| 14 | TIE1 | 1.92601135 |
| 15 | MINK1 | 1.91605800 |
| 16 | PIM1 | 1.85914565 |
| 17 | MAP3K4 | 1.65402252 |
| 18 | PHKG2 | 1.54935563 |
| 19 | PHKG1 | 1.54935563 |
| 20 | DYRK1A | 1.53889034 |
| 21 | EEF2K | 1.44073953 |
| 22 | EPHA3 | 1.42621987 |
| 23 | MAPKAPK3 | 1.35921216 |
| 24 | TXK | 1.35380847 |
| 25 | STK11 | 1.34828337 |
| 26 | WNK1 | 1.33728904 |
| 27 | MAP2K4 | 1.31278877 |
| 28 | GRK1 | 1.19302357 |
| 29 | RPS6KB2 | 1.17114111 |
| 30 | NEK2 | 1.12985381 |
| 31 | TRPM7 | 1.12665588 |
| 32 | TYRO3 | 1.10660050 |
| 33 | MAPK13 | 1.09945372 |
| 34 | BRAF | 1.07376977 |
| 35 | STK39 | 1.01507053 |
| 36 | MAP2K6 | 0.98606221 |
| 37 | CDC42BPA | 0.94113477 |
| 38 | MARK1 | 0.92915256 |
| 39 | SYK | 0.90371642 |
| 40 | BRD4 | 0.89551689 |
| 41 | LMTK2 | 0.88400370 |
| 42 | NLK | 0.87034726 |
| 43 | PRKCH | 0.85899838 |
| 44 | MAPK12 | 0.84774599 |
| 45 | DYRK2 | 0.83775604 |
| 46 | MATK | 0.81995320 |
| 47 | CSNK1D | 0.78619896 |
| 48 | MAP3K1 | 0.78249953 |
| 49 | PNCK | 0.75548414 |
| 50 | PIM2 | 0.75420688 |
| 51 | MAPKAPK5 | 0.74733130 |
| 52 | CSNK2A2 | 0.74197778 |
| 53 | MAPK15 | 0.73245959 |
| 54 | NTRK2 | 0.69430359 |
| 55 | CDK15 | 0.66126883 |
| 56 | CDK11A | 0.62946825 |
| 57 | WEE1 | 0.62681514 |
| 58 | TTN | 0.61943574 |
| 59 | CSNK1G3 | 0.61527539 |
| 60 | PRKCG | 0.60717282 |
| 61 | MAP2K7 | 0.60491770 |
| 62 | CDK18 | 0.57408225 |
| 63 | CSNK1A1 | 0.56361727 |
| 64 | CDC7 | 0.55176112 |
| 65 | UHMK1 | 0.54813561 |
| 66 | NEK9 | 0.54198258 |
| 67 | CSNK1G1 | 0.53762206 |
| 68 | FRK | 0.53052829 |
| 69 | GRK7 | 0.52416668 |
| 70 | INSRR | 0.51385469 |
| 71 | MAP2K2 | 0.50845369 |
| 72 | BMPR1B | 0.50512322 |
| 73 | ADRBK2 | 0.49614027 |
| 74 | MUSK | 0.47059133 |
| 75 | WNK3 | 0.45798084 |
| 76 | PRKCI | 0.43230438 |
| 77 | PRKCQ | 0.43130555 |
| 78 | PIK3CG | 0.43128210 |
| 79 | CDK19 | 0.42623115 |
| 80 | KIT | 0.42370754 |
| 81 | ADRBK1 | 0.41734254 |
| 82 | PRKCA | 0.40684173 |
| 83 | LCK | 0.39275448 |
| 84 | PRKCE | 0.38401303 |
| 85 | PRKACA | 0.37435795 |
| 86 | CSNK1A1L | 0.36698525 |
| 87 | CDK14 | 0.35766103 |
| 88 | MAP4K2 | 0.34640686 |
| 89 | MAPK7 | 0.33564820 |
| 90 | CDK5 | 0.32596799 |
| 91 | SIK2 | 0.32501604 |
| 92 | NEK1 | 0.32068476 |
| 93 | PIK3CA | 0.31078282 |
| 94 | CSNK1G2 | 0.29343211 |
| 95 | FGFR1 | 0.28934695 |
| 96 | RAF1 | 0.28108588 |
| 97 | CSNK1E | 0.26369792 |
| 98 | CAMK2G | 0.26334610 |
| 99 | PAK3 | 0.26240700 |
| 100 | MST1R | 0.25157372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 4.87636256 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 4.62665880 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 4.52202598 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.68863753 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.42461421 |
| 6 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 2.80058426 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.79307433 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.76103192 |
| 9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.66615203 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.59966317 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.38894728 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.26286399 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.05413464 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.87342514 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73075911 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.71914830 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.71758550 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69745873 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.57633564 |
| 20 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.55324449 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.48345709 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42212904 |
| 23 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40620000 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.38115026 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35284127 |
| 26 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.33673659 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28083035 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27427074 |
| 29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.27267393 |
| 30 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.25950513 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.16570428 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03855638 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 0.98164633 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97400794 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97132140 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 0.90552758 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90453107 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86653637 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81811937 |
| 40 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79254577 |
| 41 | RNA polymerase_Homo sapiens_hsa03020 | 0.77363279 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76986544 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76434646 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75942787 |
| 45 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75627882 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74145765 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73215230 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72320154 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64758555 |
| 50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64431602 |
| 51 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59305260 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59302463 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56153497 |
| 54 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55246652 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55239285 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54720114 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54629425 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53479260 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.52583879 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52293595 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.50977967 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49218409 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48006879 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47638850 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46768662 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43656731 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42777872 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41673169 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41595020 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40756110 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39773837 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37222786 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36855232 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35249810 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35151261 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.33977814 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31636537 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30245624 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.29866573 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25478588 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25120263 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.25009140 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24778126 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23594814 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.23293985 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23261161 |
| 87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.22174986 |
| 88 | RNA transport_Homo sapiens_hsa03013 | 0.21953420 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.21576494 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21358964 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.20537698 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.20247692 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18866872 |
| 94 | Proteasome_Homo sapiens_hsa03050 | 0.16860528 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.16644981 |
| 96 | Cocaine addiction_Homo sapiens_hsa05030 | 0.15434992 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.13777237 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.13284810 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12934457 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.12871087 |

